Experiment 356939

Worktypes

ANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

THALICARPINE

Details

PropertyValue
Pharmacology
CYTOTOXICITY ENHANCEMENT
OrganismEmpty organism
CitationCHEN,G: TEICHER,VA: FREI III,E:. (1996). DIFFERENTIAL INTERACTIONS OF PGP INHIBITOR THALIBLASTINE WITH ADRIAMYCIN, ETOPOSIDE, TAXOL AND ANTHRAPYRAZOLE C194 IN SENSITIVE AND MULTIDRUG-RESISTANT HUMAN MCF-7 BREAST CANCER CELLS.. 16(6B)
Amount utilized
Compound isolated
DiseaseCI941 CYTOTOXICITY ENHANCEMENT.
Dose amount8.0 MICROMOLS
Number2
Qualitative resultWEAK ACTIVITY
AnimalCELL CULTURE
Dose expressionCONC USED